Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage

Stroke

Volumn 43, Issue 9, 2012, Pages 2500-2502

  Switzer, Jeffrey A ^a   Rocker, Jody ^b   Mohorn, Phillip ^b   Waller, Jennifer L ^a,c   Hughes, Douglas ^b   Bruno, Askiel ^a   Nichols, Fenwick T ^a   Hess, David C ^a   Natarajan, Kavita ^b   Fagan, Susan C ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Department of Neurosurgery ^*

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

acute; intracranial hemorrhage; warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 9 COMPLEX; FRESH FROZEN PLASMA; WARFARIN;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SUDDEN DEATH; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; WARFARIN ASSOCIATED INTRACRANIAL HEMORRHAGE;

ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CEREBRAL HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAPLAN-MEIER ESTIMATE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; WARFARIN;

EID: 84865595832     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.661454     Document Type: Review

References (11)

1. Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007;120:700-705.
2. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.
3. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al. Guidelines on oral anticoagulation with warfarin-fourth edition. Br J Haematol. 2011; 154:311-324.
4. Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 2009;49:1171-1177.
5. Baggs JH, Patanwala AE, Williams EM, Erstad BL. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother. 2012;46:51-56.
6. Chong CT, Lew TWK, Kuperan P, Tan JJE, Tan HL, Kwek TK. Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates. Anaesth Intens Care. 2010;38: 474-480.
7. Imberti D, Barillari G, Biasioli C, Bianchi M, Contino L, Duce R, et al. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus. 2011;9:148-155.
8. Tran H, Collecutt M, Whitehead S, Salem HH. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Intern Med J. 2011;41:337-343.
9. Dowlatshahi D, Butcher KS, Asdaghi N, Nahirniak S, Bernbaum ML, Giulivi A, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke. 2012;43:1812-1817.
10. Majeed A, Eelde A, Agren A, Schulman S, Holmstrom M. Thrombo-embolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res. 2012;129: 146-151.
11. Steiner T, Freiberger A, Griebe M, Husing J, Ivandic B, Kollmar R, et al. International normalised ratio normalisation in patients with coumarin-related intracranial haemorrhages-the INCH trial: A randomised controlled multicentre trial to compare safety and preliminary efficacy of fresh frozen plasma and prothrombin complex-study design and protocol. Int J Stroke. 2011;6:271-277.